Cargando…
Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells
Magnesium reduces vascular smooth muscle cell (VSMC) calcification in vitro but the mechanism has not been revealed so far. This work used only slightly increased magnesium levels and aimed at determining: a) whether inhibition of magnesium transport into the cell influences VSMC calcification, b) w...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934896/ https://www.ncbi.nlm.nih.gov/pubmed/24586847 http://dx.doi.org/10.1371/journal.pone.0089525 |
_version_ | 1782305118524276736 |
---|---|
author | Montes de Oca, Addy Guerrero, Fatima Martinez-Moreno, Julio M. Madueño, Juan A. Herencia, Carmen Peralta, Alan Almaden, Yolanda Lopez, Ignacio Aguilera-Tejero, Escolastico Gundlach, Kristina Büchel, Janine Peter, Mirjam E. Passlick-Deetjen, Jutta Rodriguez, Mariano Muñoz-Castañeda, Juan R. |
author_facet | Montes de Oca, Addy Guerrero, Fatima Martinez-Moreno, Julio M. Madueño, Juan A. Herencia, Carmen Peralta, Alan Almaden, Yolanda Lopez, Ignacio Aguilera-Tejero, Escolastico Gundlach, Kristina Büchel, Janine Peter, Mirjam E. Passlick-Deetjen, Jutta Rodriguez, Mariano Muñoz-Castañeda, Juan R. |
author_sort | Montes de Oca, Addy |
collection | PubMed |
description | Magnesium reduces vascular smooth muscle cell (VSMC) calcification in vitro but the mechanism has not been revealed so far. This work used only slightly increased magnesium levels and aimed at determining: a) whether inhibition of magnesium transport into the cell influences VSMC calcification, b) whether Wnt/β-catenin signaling, a key mediator of osteogenic differentiation, is modified by magnesium and c) whether magnesium can influence already established vascular calcification. Human VSMC incubated with high phosphate (3.3 mM) and moderately elevated magnesium (1.4 mM) significantly reduced VSMC calcification and expression of the osteogenic transcription factors Cbfa-1 and osterix, and up-regulated expression of the natural calcification inhibitors matrix Gla protein (MGP) and osteoprotegerin (OPG). The protective effects of magnesium on calcification and expression of osteogenic markers were no longer observed in VSMC cultured with an inhibitor of cellular magnesium transport (2-aminoethoxy-diphenylborate [2-APB]). High phosphate induced activation of Wnt/β-catenin pathway as demonstrated by the translocation of β-catenin into the nucleus, increased expression of the frizzled-3 gene, and downregulation of Dkk-1 gene, a specific antagonist of the Wnt/β-catenin signaling pathway. The addition of magnesium however inhibited phosphate-induced activation of Wnt/β-catenin signaling pathway. Furthermore, TRPM7 silencing using siRNA resulted in activation of Wnt/β-catenin signaling pathway. Additional experiments were performed to test the ability of magnesium to halt the progression of already established VSMC calcification in vitro. The delayed addition of magnesium decreased calcium content, down-regulated Cbfa-1 and osterix and up-regulated MGP and OPG, when compared with a control group. This effect was not observed when 2-APB was added. In conclusion, magnesium transport through the cell membrane is important to inhibit VSMC calcification in vitro. Inhibition of Wnt/β-catenin by magnesium is one potential intracellular mechanism by which this anti-calcifying effect is achieved. |
format | Online Article Text |
id | pubmed-3934896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39348962014-03-04 Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells Montes de Oca, Addy Guerrero, Fatima Martinez-Moreno, Julio M. Madueño, Juan A. Herencia, Carmen Peralta, Alan Almaden, Yolanda Lopez, Ignacio Aguilera-Tejero, Escolastico Gundlach, Kristina Büchel, Janine Peter, Mirjam E. Passlick-Deetjen, Jutta Rodriguez, Mariano Muñoz-Castañeda, Juan R. PLoS One Research Article Magnesium reduces vascular smooth muscle cell (VSMC) calcification in vitro but the mechanism has not been revealed so far. This work used only slightly increased magnesium levels and aimed at determining: a) whether inhibition of magnesium transport into the cell influences VSMC calcification, b) whether Wnt/β-catenin signaling, a key mediator of osteogenic differentiation, is modified by magnesium and c) whether magnesium can influence already established vascular calcification. Human VSMC incubated with high phosphate (3.3 mM) and moderately elevated magnesium (1.4 mM) significantly reduced VSMC calcification and expression of the osteogenic transcription factors Cbfa-1 and osterix, and up-regulated expression of the natural calcification inhibitors matrix Gla protein (MGP) and osteoprotegerin (OPG). The protective effects of magnesium on calcification and expression of osteogenic markers were no longer observed in VSMC cultured with an inhibitor of cellular magnesium transport (2-aminoethoxy-diphenylborate [2-APB]). High phosphate induced activation of Wnt/β-catenin pathway as demonstrated by the translocation of β-catenin into the nucleus, increased expression of the frizzled-3 gene, and downregulation of Dkk-1 gene, a specific antagonist of the Wnt/β-catenin signaling pathway. The addition of magnesium however inhibited phosphate-induced activation of Wnt/β-catenin signaling pathway. Furthermore, TRPM7 silencing using siRNA resulted in activation of Wnt/β-catenin signaling pathway. Additional experiments were performed to test the ability of magnesium to halt the progression of already established VSMC calcification in vitro. The delayed addition of magnesium decreased calcium content, down-regulated Cbfa-1 and osterix and up-regulated MGP and OPG, when compared with a control group. This effect was not observed when 2-APB was added. In conclusion, magnesium transport through the cell membrane is important to inhibit VSMC calcification in vitro. Inhibition of Wnt/β-catenin by magnesium is one potential intracellular mechanism by which this anti-calcifying effect is achieved. Public Library of Science 2014-02-25 /pmc/articles/PMC3934896/ /pubmed/24586847 http://dx.doi.org/10.1371/journal.pone.0089525 Text en © 2014 Montes de Oca et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Montes de Oca, Addy Guerrero, Fatima Martinez-Moreno, Julio M. Madueño, Juan A. Herencia, Carmen Peralta, Alan Almaden, Yolanda Lopez, Ignacio Aguilera-Tejero, Escolastico Gundlach, Kristina Büchel, Janine Peter, Mirjam E. Passlick-Deetjen, Jutta Rodriguez, Mariano Muñoz-Castañeda, Juan R. Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells |
title | Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells |
title_full | Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells |
title_fullStr | Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells |
title_full_unstemmed | Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells |
title_short | Magnesium Inhibits Wnt/β-Catenin Activity and Reverses the Osteogenic Transformation of Vascular Smooth Muscle Cells |
title_sort | magnesium inhibits wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934896/ https://www.ncbi.nlm.nih.gov/pubmed/24586847 http://dx.doi.org/10.1371/journal.pone.0089525 |
work_keys_str_mv | AT montesdeocaaddy magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT guerrerofatima magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT martinezmorenojuliom magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT maduenojuana magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT herenciacarmen magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT peraltaalan magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT almadenyolanda magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT lopezignacio magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT aguileratejeroescolastico magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT gundlachkristina magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT bucheljanine magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT petermirjame magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT passlickdeetjenjutta magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT rodriguezmariano magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells AT munozcastanedajuanr magnesiuminhibitswntbcateninactivityandreversestheosteogenictransformationofvascularsmoothmusclecells |